Guardant Health has reported an encouraging clinical readout update on the performance of its latest algorithm for Shield ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a positive clinical readout update assessing the performance of the latest colorectal cancer (CRC) screening ...

Guardant Health (GH) announced a clinical readout update assessing the performance of the latest colorectal cancer screening algorithm for its ...

At this moment, the rugged tablet in the navigator's hand continuously displays real-time road conditions and navigation data ...

Guardant Health (NASDAQ:GH) lost ~9% in the premarket on Thursday after the company shared data from a clinical trial for its latest colorectal cancer (CRC) screening algorithm (V2) used in its Shield ...

Recent research reveals that a blank mind may be closer to your brain’s default setting, while thinking and imagining are add ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

There is a new sorting algorithm a deterministic O(m log2/3 n)-time algorithm for single-source shortest paths (SSSP) on directed graphs with real non-negative edge weights in the comparison-addition ...

If you've been noticing a distinct change in the content you're seeing on Facebook recently, you aren't alone. Several members of the IndyStar newsroom have reported seeing a disproportionate amount ...

Please provide your email address to receive an email when new articles are posted on . Early-stage CRC diagnoses in adults 45-49 doubled from 2019-2022, linked to a 62% rise in screening. Experts say ...

Guardant Health, Inc. ( NASDAQ: GH) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT ...